The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chorea Treatment Market Research Report 2025
Synopsis
Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
The global Chorea Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chorea Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chorea Treatment include Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova and Lundbeck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorea Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorea Treatment.
Report Scope
The Chorea Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorea Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorea Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech
Segment by Type
Medication
Surgery Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chorea Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
The global Chorea Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chorea Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chorea Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chorea Treatment include Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova and Lundbeck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chorea Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chorea Treatment.
Report Scope
The Chorea Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chorea Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chorea Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Aleva Neurotherapeutics
Teva Pharmaceutical
Pfizer
GlaxoSmithKline
Bausch Health Companies
LivaNova
Lundbeck
Ipsen
Alnylam Pharmaceuticals
Prana Biotechnology
RespireRx Pharmaceuticals
Vertex Pharmaceuticals
SOM Biotech
Segment by Type
Medication
Surgery Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chorea Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chorea Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medication
1.2.3 Surgery Therapy
1.3 Market by Application
1.3.1 Global Chorea Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chorea Treatment Market Perspective (2019-2030)
2.2 Chorea Treatment Growth Trends by Region
2.2.1 Global Chorea Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chorea Treatment Historic Market Size by Region (2019-2024)
2.2.3 Chorea Treatment Forecasted Market Size by Region (2025-2030)
2.3 Chorea Treatment Market Dynamics
2.3.1 Chorea Treatment Industry Trends
2.3.2 Chorea Treatment Market Drivers
2.3.3 Chorea Treatment Market Challenges
2.3.4 Chorea Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chorea Treatment Players by Revenue
3.1.1 Global Top Chorea Treatment Players by Revenue (2019-2024)
3.1.2 Global Chorea Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chorea Treatment Revenue
3.4 Global Chorea Treatment Market Concentration Ratio
3.4.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2023
3.5 Chorea Treatment Key Players Head office and Area Served
3.6 Key Players Chorea Treatment Product Solution and Service
3.7 Date of Enter into Chorea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chorea Treatment Breakdown Data by Type
4.1 Global Chorea Treatment Historic Market Size by Type (2019-2024)
4.2 Global Chorea Treatment Forecasted Market Size by Type (2025-2030)
5 Chorea Treatment Breakdown Data by Application
5.1 Global Chorea Treatment Historic Market Size by Application (2019-2024)
5.2 Global Chorea Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chorea Treatment Market Size (2019-2030)
6.2 North America Chorea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chorea Treatment Market Size by Country (2019-2024)
6.4 North America Chorea Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chorea Treatment Market Size (2019-2030)
7.2 Europe Chorea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chorea Treatment Market Size by Country (2019-2024)
7.4 Europe Chorea Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chorea Treatment Market Size (2019-2030)
8.2 Asia-Pacific Chorea Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chorea Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Chorea Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chorea Treatment Market Size (2019-2030)
9.2 Latin America Chorea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chorea Treatment Market Size by Country (2019-2024)
9.4 Latin America Chorea Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chorea Treatment Market Size (2019-2030)
10.2 Middle East & Africa Chorea Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chorea Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Chorea Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Chorea Treatment Introduction
11.1.4 Medtronic Revenue in Chorea Treatment Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Chorea Treatment Introduction
11.2.4 Boston Scientific Revenue in Chorea Treatment Business (2019-2024)
11.2.5 Boston Scientific Recent Development
11.3 Aleva Neurotherapeutics
11.3.1 Aleva Neurotherapeutics Company Detail
11.3.2 Aleva Neurotherapeutics Business Overview
11.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction
11.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2019-2024)
11.3.5 Aleva Neurotherapeutics Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Detail
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Chorea Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2019-2024)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chorea Treatment Introduction
11.5.4 Pfizer Revenue in Chorea Treatment Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Detail
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chorea Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2019-2024)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Detail
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Chorea Treatment Introduction
11.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2019-2024)
11.7.5 Bausch Health Companies Recent Development
11.8 LivaNova
11.8.1 LivaNova Company Detail
11.8.2 LivaNova Business Overview
11.8.3 LivaNova Chorea Treatment Introduction
11.8.4 LivaNova Revenue in Chorea Treatment Business (2019-2024)
11.8.5 LivaNova Recent Development
11.9 Lundbeck
11.9.1 Lundbeck Company Detail
11.9.2 Lundbeck Business Overview
11.9.3 Lundbeck Chorea Treatment Introduction
11.9.4 Lundbeck Revenue in Chorea Treatment Business (2019-2024)
11.9.5 Lundbeck Recent Development
11.10 Ipsen
11.10.1 Ipsen Company Detail
11.10.2 Ipsen Business Overview
11.10.3 Ipsen Chorea Treatment Introduction
11.10.4 Ipsen Revenue in Chorea Treatment Business (2019-2024)
11.10.5 Ipsen Recent Development
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Company Detail
11.11.2 Alnylam Pharmaceuticals Business Overview
11.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction
11.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024)
11.11.5 Alnylam Pharmaceuticals Recent Development
11.12 Prana Biotechnology
11.12.1 Prana Biotechnology Company Detail
11.12.2 Prana Biotechnology Business Overview
11.12.3 Prana Biotechnology Chorea Treatment Introduction
11.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2019-2024)
11.12.5 Prana Biotechnology Recent Development
11.13 RespireRx Pharmaceuticals
11.13.1 RespireRx Pharmaceuticals Company Detail
11.13.2 RespireRx Pharmaceuticals Business Overview
11.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction
11.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024)
11.13.5 RespireRx Pharmaceuticals Recent Development
11.14 Vertex Pharmaceuticals
11.14.1 Vertex Pharmaceuticals Company Detail
11.14.2 Vertex Pharmaceuticals Business Overview
11.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction
11.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024)
11.14.5 Vertex Pharmaceuticals Recent Development
11.15 SOM Biotech
11.15.1 SOM Biotech Company Detail
11.15.2 SOM Biotech Business Overview
11.15.3 SOM Biotech Chorea Treatment Introduction
11.15.4 SOM Biotech Revenue in Chorea Treatment Business (2019-2024)
11.15.5 SOM Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Chorea Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medication
Table 3. Key Players of Surgery Therapy
Table 4. Global Chorea Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Chorea Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Chorea Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Chorea Treatment Market Share by Region (2019-2024)
Table 8. Global Chorea Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Chorea Treatment Market Share by Region (2025-2030)
Table 10. Chorea Treatment Market Trends
Table 11. Chorea Treatment Market Drivers
Table 12. Chorea Treatment Market Challenges
Table 13. Chorea Treatment Market Restraints
Table 14. Global Chorea Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Chorea Treatment Market Share by Players (2019-2024)
Table 16. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorea Treatment as of 2023)
Table 17. Ranking of Global Top Chorea Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Chorea Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chorea Treatment Product Solution and Service
Table 21. Date of Enter into Chorea Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chorea Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Chorea Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Chorea Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Chorea Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Chorea Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Chorea Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Chorea Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Chorea Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Chorea Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Chorea Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Chorea Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Chorea Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Chorea Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Chorea Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Chorea Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Chorea Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Chorea Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chorea Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Chorea Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Chorea Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Chorea Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Chorea Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Chorea Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Chorea Treatment Product
Table 49. Medtronic Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Boston Scientific Company Detail
Table 52. Boston Scientific Business Overview
Table 53. Boston Scientific Chorea Treatment Product
Table 54. Boston Scientific Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 55. Boston Scientific Recent Development
Table 56. Aleva Neurotherapeutics Company Detail
Table 57. Aleva Neurotherapeutics Business Overview
Table 58. Aleva Neurotherapeutics Chorea Treatment Product
Table 59. Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 60. Aleva Neurotherapeutics Recent Development
Table 61. Teva Pharmaceutical Company Detail
Table 62. Teva Pharmaceutical Business Overview
Table 63. Teva Pharmaceutical Chorea Treatment Product
Table 64. Teva Pharmaceutical Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 65. Teva Pharmaceutical Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Chorea Treatment Product
Table 69. Pfizer Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. GlaxoSmithKline Company Detail
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Chorea Treatment Product
Table 74. GlaxoSmithKline Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Bausch Health Companies Company Detail
Table 77. Bausch Health Companies Business Overview
Table 78. Bausch Health Companies Chorea Treatment Product
Table 79. Bausch Health Companies Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 80. Bausch Health Companies Recent Development
Table 81. LivaNova Company Detail
Table 82. LivaNova Business Overview
Table 83. LivaNova Chorea Treatment Product
Table 84. LivaNova Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 85. LivaNova Recent Development
Table 86. Lundbeck Company Detail
Table 87. Lundbeck Business Overview
Table 88. Lundbeck Chorea Treatment Product
Table 89. Lundbeck Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 90. Lundbeck Recent Development
Table 91. Ipsen Company Detail
Table 92. Ipsen Business Overview
Table 93. Ipsen Chorea Treatment Product
Table 94. Ipsen Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 95. Ipsen Recent Development
Table 96. Alnylam Pharmaceuticals Company Detail
Table 97. Alnylam Pharmaceuticals Business Overview
Table 98. Alnylam Pharmaceuticals Chorea Treatment Product
Table 99. Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 100. Alnylam Pharmaceuticals Recent Development
Table 101. Prana Biotechnology Company Detail
Table 102. Prana Biotechnology Business Overview
Table 103. Prana Biotechnology Chorea Treatment Product
Table 104. Prana Biotechnology Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 105. Prana Biotechnology Recent Development
Table 106. RespireRx Pharmaceuticals Company Detail
Table 107. RespireRx Pharmaceuticals Business Overview
Table 108. RespireRx Pharmaceuticals Chorea Treatment Product
Table 109. RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 110. RespireRx Pharmaceuticals Recent Development
Table 111. Vertex Pharmaceuticals Company Detail
Table 112. Vertex Pharmaceuticals Business Overview
Table 113. Vertex Pharmaceuticals Chorea Treatment Product
Table 114. Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 115. Vertex Pharmaceuticals Recent Development
Table 116. SOM Biotech Company Detail
Table 117. SOM Biotech Business Overview
Table 118. SOM Biotech Chorea Treatment Product
Table 119. SOM Biotech Revenue in Chorea Treatment Business (2019-2024) & (US$ Million)
Table 120. SOM Biotech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chorea Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chorea Treatment Market Share by Type: 2023 VS 2030
Figure 3. Medication Features
Figure 4. Surgery Therapy Features
Figure 5. Global Chorea Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Chorea Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Chorea Treatment Report Years Considered
Figure 11. Global Chorea Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Chorea Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Chorea Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Chorea Treatment Market Share by Players in 2023
Figure 15. Global Top Chorea Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chorea Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Chorea Treatment Revenue in 2023
Figure 17. North America Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Chorea Treatment Market Share by Country (2019-2030)
Figure 19. United States Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Chorea Treatment Market Share by Country (2019-2030)
Figure 23. Germany Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Chorea Treatment Market Share by Region (2019-2030)
Figure 31. China Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Chorea Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Chorea Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Chorea Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 46. Boston Scientific Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 47. Aleva Neurotherapeutics Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 48. Teva Pharmaceutical Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 51. Bausch Health Companies Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 52. LivaNova Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 53. Lundbeck Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 54. Ipsen Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 55. Alnylam Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 56. Prana Biotechnology Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 57. RespireRx Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 58. Vertex Pharmaceuticals Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 59. SOM Biotech Revenue Growth Rate in Chorea Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
